2.000
−13,04%
2026-08-19
Fundamental Analysis
33 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -118.2% | +35.4% | 2 / 3 | -81.4% | -6.66 pp | -119.70 pp | -6.2% | 0.00 | — | 0,6 | −81,4% | −0,3 | −118,2% | — | -2.82 | — |
| Pts | 0 | 8 | 8 | 0 | 0 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 2.000 (close price on 2026-08-19)EPS (TTM): −364,8
Financial charts
1.Revenue & growth
VND bn0,56Q2/26
1.Revenue & growth
VND bn0,56Q2/26
2.Profit & growth
VND bn-0,33Q2/26
3.Profit mix (Penman)
VND bn-0,73Q2/26
4.Margins & cost structure
%28.0%Q2/26
5.Returns & cash cycle
% · days
6.Earnings quality & cash
VND bn-0,32Q2/26
7.Asset structure
VND bn15,8Q2/26
8.Funding & debt health
VND bn · times15,8Q2/26
9.Revenue backlog
VND bn0,46Q2/26
10.Valuation
times · %-5,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-165Q2/26
Adjusted EPS growth, latest quarter
-118%
Average adjusted EPS growth, 3 quarters
-118%
averaged over 1 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26